Skip to content

← All stories

Markets

Mendus narrows Q2 loss as blood cancer trials advance

1 source ·2 articles ·1h ago

Covered by 1 outlet

All coverage · 2 articles

Investing.com UK ·1h ago

Mendus narrows Q2 loss as blood cancer trials advance

Investing.com Stock Market ·1h ago

Mendus narrows Q2 loss as blood cancer trials advance